Monofunctional BODIPY-Appended Imidazoplatin for Cellular Imaging and Mitochondria-Targeted Photocytotoxicity
- 28 August 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 56 (18) , 11019-11029
Abstract
Monofunctional platinum(II) complexes of formulation cis-[Pt(NH3)2(L)Cl](NO3), where L is an imidazole base conjugated to 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) with emissive (L1 in 1) and nonemissive (L2 in 2) moieties were prepared and characterized, and their singlet oxygen-mediated photoinduced cytotoxicity was studied. The 1-methylimidazole (1-MeIm) complex 3 was prepared as a control and for structural characterization by X-ray crystallography. Complexes 1 and 2 showed strong visible absorption bands at 500 nm (ε = 2.7 × 104 M–1 cm–1) and 540 nm (1.4 × 104 M–1 cm–1). Complex 1 is emissive with a band at 510 nm (ΦF = 0.09) in 1% dimethyl sulfoxide/Dulbecco’s Modified Eagle’s Medium (pH 7.2). Singlet oxygen generation upon photoirradiation with visible light (400–700 nm) was evidenced from 1,3-diphenylisobenzofuran titration experiments showing significant photosensitizing ability of the BODIPY complexes. Both 1 and 2 were remarkably photocytotoxic in visible light (400–700 nm, 10 J cm–2) in skin keratinocyte HaCaT and breast cancer MCF-7 cells giving IC50 values in nanomolar concentration. The complexes were, however, essentially nontoxic to the cells in the dark (IC50 > 80 μM). Complex 2 having a diiodo-BODIPY unit is nonemissive but an efficient photosensitizer with high singlet oxygen generation ability in visible light (400–700 nm). Confocal microscopy using the emissive complex 1 showed significant mitochondrial localization of the complex. Cell death via apoptotic pathway was observed from the Annexin-V-FITC/PI assay. The formation of Pt-DNA adducts was evidenced from the binding experiments of the complexes 1 and 2 with 9-ethylguanine as a model nucleobase from 1H NMR and mass spectral studies.Keywords
Funding Information
- Council of Scientific and Industrial Research
- Indian Institute of Science
- Department of Biotechnology , Ministry of Science and Technology
- Department of Science and Technology, Ministry of Science and Technology (EMR/2015/000742, SR/S5/MBD-02/2007)
This publication has 62 references indexed in Scilit:
- The Platin-X series: activation, targeting, and deliveryDalton Transactions, 2016
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsChemical Reviews, 2016
- A Potent Glucose–Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer CellsAngewandte Chemie International Edition, 2016
- Multifunctional Pt(II) Reagents: Covalent Modifications of Pt Complexes Enable Diverse Structural Variation and In-Cell DetectionAccounts of Chemical Research, 2015
- Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein BindingInorganic Chemistry, 2015
- Multi-platinum anti-cancer agents. Substitution-inert compounds for tumor selectivity and new targetsChemical Society Reviews, 2015
- Synthetic Methods for the Preparation of Platinum Anticancer ComplexesChemical Reviews, 2013
- Targeting and delivery of platinum-based anticancer drugsChemical Society Reviews, 2012
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticlesProceedings of the National Academy of Sciences, 2008
- A potent cytotoxic photoactivated platinum complexProceedings of the National Academy of Sciences, 2007